comparemela.com

Sancti Spiritus, Cuba, Aug 17 (Prensa Latina) The phase III clinical trial to evaluate the efficacy and safety of the neuroprotective drug NeuralCIM in patients with mild or moderate Alzheimer's amnestic variant is progressing positively today in this central province of Cuba.

Related Keywords

Villa Clara ,Cienfuegos ,Cuba ,Havana ,Ciudad De La Habana ,Fomento ,Camagü ,Yaguajay ,Sancti Spítus ,Camilo Cienfuegos ,Provincia De Mayabeque ,Cuban ,Imey Hern ,Molecular Immunology Center ,Department Of Demography ,Camilo Cienfuegos General Provincial ,State Control ,Medical Devices ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.